Effects of antioxidant stobadine on protein carbonylation, advanced oxidation protein products and reductive capacity of liver in streptozotocin-diabetic rats: Role of oxidative/nitrosative stress

BioFactors

Volumn 30, Issue 3, 2007, Pages 171-178

  Cumaoǧlu, Ahmet ^a   Çevik, Cemal ^a   Rackova, Lucia ^b   Ari, Nuray ^c   Karasu, Çimen ^a  

^a GAZI UNIVERSITY   (Turkey)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Advanced oxidation protein products; Carbonyl; Diabetes; Nitrosative stress; Nitrotyrosine; Oxidative stress; Protein oxidation; Stobadine; Thiol

Indexed keywords

3 NITROTYROSINE; ADVANCED OXIDATION PROTEIN PRODUCT; ANTIOXIDANT; BIOLOGICAL MARKER; CARBOLINE DERIVATIVE; CARBONYL DERIVATIVE; GLUCOSE; LIVER PROTEIN; REACTIVE OXYGEN METABOLITE; STOBADINE; STREPTOZOCIN; THIOL DERIVATIVE; THIOL GROUP;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BODY WEIGHT; COLORIMETRY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC COMPLICATION; DRUG EFFECT; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HYPERGLYCEMIA; LIVER; LIVER HOMOGENATE; MALE; NITROSATIVE STRESS; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN DEGRADATION; RAT; SINGLE DRUG DOSE; STATISTICAL ANALYSIS; TISSUE INJURY; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; CARBOLINES; DIABETES MELLITUS, EXPERIMENTAL; LIVER; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; STREPTOZOCIN; SULFHYDRYL COMPOUNDS; TYROSINE;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 47849124034     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520300304     Document Type: Article

References (33)

1. M. Brownlee, A. Cerami and H. Vlassura, Advanced glycosylation end products in tissue and the biochemical basis of diabetes complication, The New Engl J Med 318 (1988), 1315-1321.
2. M. Brownlee, Glycation and diabetic complications, Diabetes 43 (1994), 836-841.
3. R.T. Dean, S. Fu, R. Stocker and M.J. Davies, Biochemistry and pathology of radical-mediated protein oxidation, Biochem J 324 (1997), 1-18.
4. E.M. Ellis, Reactive carbonyls and oxidative stress: potential for therapeutic intervention, Pharmacol Ther 115 (2007), 13-24.
5. A. Gunes, A. Ceylan, Y. Sarioglu, M. Stefek, V. Bauer and C. Karasu, The Antioxidants in Diabetes-induced Complications (ADIC) Study Group. Reactive oxygen species mediate abnormal contractile response to sympathetic nerve stimulation and noradrenaline in the vas deferens of chronically diabetic rats: effects of in vivo treatment with antioxidants, Fundam Clin Pharmacol 19 (2006), 73-79.
6. L. Horakova and S. Stolc, Antioxidant and pharmacodynamic effects of pyridoindole stobadine, Gen Pharmacol 30 (1998), 627-638.
7. H. Ischiropoulos and A.B. Al-Mehdi, Peroxynitrite-mediated oxidative protein modification, FEBS Lett 364 (1995), 279-282.
8. A.S. Januszewski, N.L. Alderson, T.O. Metz, S.R. Thorpe and J.W. Baynes, Role of lipids in chemical modification of proteins and development of complications in diabetes, Biochem Soc Trans 31 (2003), 1413-1416.
9. D.P. Jones, Redefining oxidative stress, Antioxid Redox Signal 8 (2006), 1865-1879.
10. V.E. Kagan, M. Tsuchiya, E. Serbinova, L. Packer and H. Sies, Interaction of the pyridoindole stobadine with peroxyl, superoxide and chromanoxyl radicals, Biochem Pharmacol 45 (1993), 393-400.
11. R. Kayali, A. Telci, U. Cakatay, C. Karaca, T. Akcay, A. Sivas and T. Altug, Oxidative protein damage parameters in plasma in chronic experimental diabetes in rats, Eur J Med Res 8 (2003), 307-312.
12. Z. Kyselova, A. Gajdosik, A. Gajdosikova, O. Ulicna, D. Mihalova, C. Karasu and M. Stefek, Effect of the pyridoindole antioxidant stobadine on development of experimental diabetic cataract and on lens protein oxidation in rats: comparison with vitamin E and BHT, Mol Vis 11 (2005), 56-65.
13. O.H. Lowry, N.J. Rosebrough, A.L. Farr and R.J. Randall, Protein measurement with the Folin phenol reagent, J Biol Chem 193 (1951), 265-275.
14. F. Mercuri, L. Quagliaro and A. Ceriello, Oxidative stress evaluation in diabetes, Diabetes Technol Ther 2 (2000), 589-600.
15. T.O. Metz, N.L. Alderson, M.E. Chachich, S.R. Thorpe and J.W. Baynes, Pyridoxamine traps intermediates in lipid peroxidation reactions in vivo: evidence on the role of lipids in chemical modification of protein and development of diabetic complications, J Biol Chem 278 (2003), 42012-42019.
16. T. Miyata, N. Ishikawa and C. van Ypersele de Strihou, Carbonyl stress and diabetic complications, Clin Chem Lab Med 41 (2003), 1150-1158.
17. A.D. Mooradian, D. Reinacher, J.P. Li and J.L. Pinnas, Malondialdehyde modification of proteins in vitro is enhanced in the presence of acetaldehyde, Nutrition 17 (2001), 619-622.
18. P. Pacher, I.G. Obrosova, J.G. Mabley and C. Szabo, Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies, Curr Med Chem 12 (2005), 267-275.
19. +-ATPase activity in heart and liver of streptozotocin-diabetic rats: comparison with vitamin E, Biochim Biophys Acta 1588 (2002), 71-78.
20. S. Pennathur and J.W. Heinecke, Mechanisms for oxidative stress in diabetic cardiovascular disease, Antioxid Redox Signal 9 (2007), 955-969.
21. A. Piwowar, M. Knapik-Kordecka and M. Warwas, AOPP and its relations with selected markers of oxidative/antioxidative system in type 2 diabetes mellitus, Diabetes Res Clin Pract 77 (2007), 188-192.
22. T. Sato, M. Iwaki, N. Shimogaito, X. Wu, S. Yamagishi and M. Takeuchi, TAGE (toxic AGEs) theory in diabetic complications, Curr Mol Med 6 (2006), 351-338.
23. J. Sedlak and R.H. Lindsay, Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent, Anal Biochem 25 (1968), 192-205.
24. P. Song, Y. Wu, J. Xu, Z. Xie, Y. Dong, M. Zhang and M.H. Zou, Reactive nitrogen species induced by hyperglycemia suppresses Akt signaling and triggers apoptosis by upregulating phosphatase PTEN (phosphatase and tensin homologue deleted on chromosome 10) in an LKB1-dependent manner, Circulation 116 (2007), 1585-1595.
25. M. Stefek, I. Drozdikova and K. Vajdova, The pyridoindole antioxidant stobadine inhibited glycation-induced absorbance and fluorescence changes in albumin, Acta Diabetol 33 (1996), 35-40.
26. M. Stefek, A. Gajdosik, N. Tribulova, J. Navarova, K. Volkovova, P. Weismann, A. Gajdosikova, J. Drimal and D. Mihalova, The pyridoindole antioxidant stobadine attenuates albuminuria, enzymuria, kidney lipid peroxidation and matrix collagen cross-linking in streptozotocin-induced diabetic rats, Methods Find Exp Clin Pharmacol 24 (2002), 565-571.
27. M. Stefek, L. Krizanova and Z. Trnkova, Oxidative modification of serum albumin in an experimental glycation model of diabetes mellitus in vitro: effect of the pyridoindole antioxidant stobadine, Life Sci 65 (1999), 1995-1997.
28. M. Stefek, R. Sotnikova, L. Okruhlicova, K. Volkovova, J. Kucharska, A. Gajdosik, A. Gajdosikova, D. Mihalova, R. Hozova, N. Tribulova and A. Gvozdjakova, Effect of dietary supplementation with the pyridoindole antioxidant stobadine on antioxidant state and ultrastructure of diabetic rat myocardium, Acta Diabetol 37 (2000), 111-117.
29. A. Telci, U. Cakatay, S. Salman, I. Satman and A. Sivas, Oxidative protein damage in early stage Type 1 diabetic patients, Diabetes Res Clin Pract 50 (2000), 213-223.
30. N.N. Ulusu, M. Sahilli, A. Avci, O. Canbolat, G. Ozansoy, N. Ari, M. Bali, M. Stefek, S. Stolc, A. Gajdosik and C. Karasu, Pentose phosphate pathway, glutathione-dependent enzymes and antioxidant defense during oxidative stress in diabetic rodent brain and peripheral organs: effects of stobadine and vitamin E, Neurochem Res 28 (2003), 815-823.
31. V. Witko-Sarsat, M. Friedlander, T. Nguyen-Khoa, C. Capeillere-Blandin, Ah Nguyen, S. Canterloup, Jm Drayer, P. Jungers and T. Drueke, Deschamps-Latscha B: Advanced oxidation protein products as novel mediator of inflammation and monocyte activation in chronic renal failure, J Immunol 161 (1998), 2524-2532.
32. F. Yülek, M. Or, C. Ozoǧul, A.C. Isik, N. Ari, M. Stefek, V. Bauer and C. Karasu, Effects of stobadine and vitamin E in diabetes-induced retinal abnormalities: involvement of oxidative stres, Arch Med Res 38 (2007), 503-511.
33. Z. Yildirim, N.I. Ucgun, N. Kilic, E. Gursel and A. Sepici-Dincel, Antioxidant enzymes and diabetic retinopathy, Ann N Y Acad Sci 1100 (2007), 199-206.